Pharmafile Logo
Pharmafocus logo
Advanced Search

Cancer Drugs Fund

Showing 15 posts of 53 posts found.

Pfizer’s blood cancer drug first to be reappraised from Cancer Drug Fund

July 7, 2016
Research and Development, Sales and Marketing Cancer, Cancer Drugs Fund, NICE, Pfizer, blood cancer, bosulif

The National Institute for Health and Care Excellence (Nice) recommended US pharma giant Pfizer’s (NYSE: PFE) Bosulif (bosutinib) to treat …

News
eli_lilly_logo

Nice does not recommend Eli Lilly’s lung cancer drug in draft guidance

May 26, 2016
Research and Development, Sales and Marketing Cancer Drugs Fund, Eli Lilly, NICE, lung cancer

The National Institute of Care and Excellence (Nice) did not recommend US drugmaker Eli Lilly’s (NYSE: LLY) Portrazza to treat …

News
jevtana

A win for Sanofi on Jevtana after NICE reverses guidance

April 22, 2016
Medical Communications, Sales and Marketing Cancer Drugs Fund, Jevtana, NICE, Sanofi, recommendation, reversal

Prostate cancer treatment Jevtana (cabazitaxel), marketed by Sanofi (NYSE: SNY) has been recommended by NICE in its final guidance. The …

News
janssen_latest_logo_on_sign

Janssen slams NICE decision on Imbruvica

March 2, 2016
Research and Development, Sales and Marketing CLL, Cancer, Cancer Drugs Fund, Janssen, Johnson & Johnson, NICE, imbruvica

Janssen, the R&D arm of pharma major Johnson & Johnson, says it is extremely disappointed following regulator NICE’s announcement that …

News
eisai_logo

Eisai slams new Cancer Drugs Fund for delaying patient access

February 26, 2016
Research and Development, Sales and Marketing Cancer Drugs Fund, Eisai, Lenvima

Eisai has aimed strong criticism at NHS England for its approval of reforms to the Cancer Drugs Fund, calling the …

News

INTERVIEW: AstraZeneca on the Cancer Drugs Fund reforms

February 26, 2016
Medical Communications, Research and Development, Sales and Marketing Cancer Drugs Fund

Greg Rossi, head of the Oncology Business Unit, AstraZeneca UK and Ireland, and the company’s market access team, spoke to …

Feature
nhs_sign

NHS England approves Cancer Drugs Fund proposals

February 26, 2016
Medical Communications, Research and Development ABPI, Cancer Drugs Fund, NHS England

NHS England has approved proposed reforms of the Cancer Drugs Fund, following the end of the 12-week consultation period earlier …

News

Novartis says CDF proposals place “unreasonable” risk on pharma

February 10, 2016
Medical Communications, Research and Development, Sales and Marketing Cancer Drugs Fund, NHS England, NICE, Novartis

Novartis has criticised some of the proposed changes to the way in which the UK Cancer Drugs Fund (CDF) is …

News

Parliamentary committee says CDF must make better use of taxpayer money

February 5, 2016
Medical Communications Cancer Drugs Fund, Public Accounts Committee

The Cancer Drugs Fund, set up to improve patients’ access to cancer drugs, has not been managed effectively, a UK …

News
Chemotherapy

A brighter future for the Cancer Drugs Fund?

January 14, 2016
Sales and Marketing Cancer Drugs Fund, NHS England, NICE, Prostate Cancer UK

In November 2015, NICE and NHS England announced proposed changes to the operation of the Cancer Drugs Fund. This is …

Feature
nhs_england_and_nice_logos

NHS England and NICE announce plans for new Cancer Drugs Fund

November 19, 2015
Medical Communications, Research and Development Cancer Drugs Fund, NHS England, NICE

A 12-week consultation on draft proposals for a revamped Cancer Drugs Fund (CDF) has been launched by NHS England and NICE, …

News

NICE rejects Roche’s Kadcyla for NHS; price still too high

November 17, 2015
Manufacturing and Production, Sales and Marketing Cancer Drugs Fund, Kadcyla, NHS England, NICE, Roche

NICE has published final draft guidance on Roche’s Kadcyla as a breast cancer treatment, deciding that the drug’s price remains …

News

NHS England reinstates treatments to Cancer Drugs Fund

November 4, 2015
Sales and Marketing Cancer, Cancer Drugs Fund, NHS, NHS England

Five treatments in seven indications have been reinstated to Cancer Drugs Fund, as a result of negotiations between pharma companies …

News
Kadcyla

Roche under pressure to drop price of Kadcyla

October 27, 2015
Manufacturing and Production Cancer Drugs Fund, Kadcyla, Roche, breast cancer

The UK’s largest breast cancer charity has called for drug manufacturer Roche to drop the price of Kadcyla before it …

News
abpi_acting_ceo_alison_clough

ABPI responds to UK medicines cost controversy

September 25, 2015
Medical Communications, Sales and Marketing ABPI, Cancer Drugs Fund, NHS

Alison Clough, acting CEO of the Association of the British Pharmaceutical Industry (ABPI), has responded to recent reports in the …

News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026